Industry Research Reports

Home > Reports > Service & Software > Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published Date: 2024-01-24

Pages: 123 Pages

Report ld: 2343092

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Personalized Medicines Market Size(US$)

CAGR 2024-2030

10.9%

Market Size,2030

USD 540,120

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 291,120 million

Market Forecast in 2030(Value)

US$ 540,120 million

CAGR

10.9%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.

The global market for Personalized Medicines was estimated to be worth US$ 259380 million in 2023 and is forecast to a readjusted size of US$ 540120 million by 2030 with a CAGR of 10.9% during the forecast period 2024-2030

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness

Segment by Application

Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Personalized Medicines, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Personalized Medicines by region & country, by Type, and by Application.

The Personalized Medicines market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Personalized Medicines manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Personalized Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Personalized Medicines in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Personalized Medicines Product Introduction

1.2 Global Personalized Medicines Market Size Forecast

1.3 Personalized Medicines Market Trends & Drivers

1.3.1 Personalized Medicines Industry Trends

1.3.2 Personalized Medicines Market Drivers & Opportunity

1.3.3 Personalized Medicines Market Challenges

1.3.4 Personalized Medicines Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Personalized Medicines Players Revenue Ranking (2023)

2.2 Global Personalized Medicines Revenue by Company (2019-2024)

2.3 Key Companies Personalized Medicines Manufacturing Base Distribution and Headquarters

2.4 Key Companies Personalized Medicines Product Offered

2.5 Key Companies Time to Begin Mass Production of Personalized Medicines

2.6 Personalized Medicines Market Competitive Analysis

2.6.1 Personalized Medicines Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Personalized Medicines Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 PM Diagnostics

3.1.2 PM Therapeutics

3.1.3 Personalized Medical Care

3.1.4 Personalized Nutrition & Wellness

3.2 Global Personalized Medicines Sales Value by Type

3.2.1 Global Personalized Medicines Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Personalized Medicines Sales Value, by Type (2019-2030)

3.2.3 Global Personalized Medicines Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals Pharmacies

4.1.2 Retail Pharmacies

4.1.3 Dietary Care Centers

4.1.4 Others

4.2 Global Personalized Medicines Sales Value by Application

4.2.1 Global Personalized Medicines Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Personalized Medicines Sales Value, by Application (2019-2030)

4.2.3 Global Personalized Medicines Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Personalized Medicines Sales Value by Region

5.1.1 Global Personalized Medicines Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Personalized Medicines Sales Value by Region (2019-2024)

5.1.3 Global Personalized Medicines Sales Value by Region (2025-2030)

5.1.4 Global Personalized Medicines Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Personalized Medicines Sales Value, 2019-2030

5.2.2 North America Personalized Medicines Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Personalized Medicines Sales Value, 2019-2030

5.3.2 Europe Personalized Medicines Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Personalized Medicines Sales Value, 2019-2030

5.4.2 Asia Pacific Personalized Medicines Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Personalized Medicines Sales Value, 2019-2030

5.5.2 South America Personalized Medicines Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Personalized Medicines Sales Value, 2019-2030

5.6.2 Middle East & Africa Personalized Medicines Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Personalized Medicines Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Personalized Medicines Sales Value

6.3 United States

6.3.1 United States Personalized Medicines Sales Value, 2019-2030

6.3.2 United States Personalized Medicines Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Personalized Medicines Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Personalized Medicines Sales Value, 2019-2030

6.4.2 Europe Personalized Medicines Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Personalized Medicines Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Personalized Medicines Sales Value, 2019-2030

6.5.2 China Personalized Medicines Sales Value by Type (%), 2023 VS 2030

6.5.3 China Personalized Medicines Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Personalized Medicines Sales Value, 2019-2030

6.6.2 Japan Personalized Medicines Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Personalized Medicines Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Personalized Medicines Sales Value, 2019-2030

6.7.2 South Korea Personalized Medicines Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Personalized Medicines Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Personalized Medicines Sales Value, 2019-2030

6.8.2 Southeast Asia Personalized Medicines Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Personalized Medicines Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Personalized Medicines Sales Value, 2019-2030

6.9.2 India Personalized Medicines Sales Value by Type (%), 2023 VS 2030

6.9.3 India Personalized Medicines Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 3G Biotech

7.1.1 3G Biotech Profile

7.1.2 3G Biotech Main Business

7.1.3 3G Biotech Personalized Medicines Products, Services and Solutions

7.1.4 3G Biotech Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.1.5 3G Biotech Recent Developments

7.2 Quest Diagnostics

7.2.1 Quest Diagnostics Profile

7.2.2 Quest Diagnostics Main Business

7.2.3 Quest Diagnostics Personalized Medicines Products, Services and Solutions

7.2.4 Quest Diagnostics Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.2.5 Quest Diagnostics Recent Developments

7.3 Laboratory Corporation of America

7.3.1 Laboratory Corporation of America Profile

7.3.2 Laboratory Corporation of America Main Business

7.3.3 Laboratory Corporation of America Personalized Medicines Products, Services and Solutions

7.3.4 Laboratory Corporation of America Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.3.5 Abbott Recent Developments

7.4 Abbott

7.4.1 Abbott Profile

7.4.2 Abbott Main Business

7.4.3 Abbott Personalized Medicines Products, Services and Solutions

7.4.4 Abbott Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.4.5 Abbott Recent Developments

7.5 Agendia NV

7.5.1 Agendia NV Profile

7.5.2 Agendia NV Main Business

7.5.3 Agendia NV Personalized Medicines Products, Services and Solutions

7.5.4 Agendia NV Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.5.5 Agendia NV Recent Developments

7.6 Asuragen Inc

7.6.1 Asuragen Inc Profile

7.6.2 Asuragen Inc Main Business

7.6.3 Asuragen Inc Personalized Medicines Products, Services and Solutions

7.6.4 Asuragen Inc Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.6.5 Asuragen Inc Recent Developments

7.7 Becton Dickinson

7.7.1 Becton Dickinson Profile

7.7.2 Becton Dickinson Main Business

7.7.3 Becton Dickinson Personalized Medicines Products, Services and Solutions

7.7.4 Becton Dickinson Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.7.5 Becton Dickinson Recent Developments

7.8 CardioDx Inc.

7.8.1 CardioDx Inc. Profile

7.8.2 CardioDx Inc. Main Business

7.8.3 CardioDx Inc. Personalized Medicines Products, Services and Solutions

7.8.4 CardioDx Inc. Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.8.5 CardioDx Inc. Recent Developments

7.9 Foundation Medicine

7.9.1 Foundation Medicine Profile

7.9.2 Foundation Medicine Main Business

7.9.3 Foundation Medicine Personalized Medicines Products, Services and Solutions

7.9.4 Foundation Medicine Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.9.5 Foundation Medicine Recent Developments

7.10 Qiagen

7.10.1 Qiagen Profile

7.10.2 Qiagen Main Business

7.10.3 Qiagen Personalized Medicines Products, Services and Solutions

7.10.4 Qiagen Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.10.5 Qiagen Recent Developments

7.11 Siemens Healthcare

7.11.1 Siemens Healthcare Profile

7.11.2 Siemens Healthcare Main Business

7.11.3 Siemens Healthcare Personalized Medicines Products, Services and Solutions

7.11.4 Siemens Healthcare Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.11.5 Siemens Healthcare Recent Developments

7.12 Amgen

7.12.1 Amgen Profile

7.12.2 Amgen Main Business

7.12.3 Amgen Personalized Medicines Products, Services and Solutions

7.12.4 Amgen Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.12.5 Amgen Recent Developments

7.13 Bristol-Myers Squibb

7.13.1 Bristol-Myers Squibb Profile

7.13.2 Bristol-Myers Squibb Main Business

7.13.3 Bristol-Myers Squibb Personalized Medicines Products, Services and Solutions

7.13.4 Bristol-Myers Squibb Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.13.5 Bristol-Myers Squibb Recent Developments

7.14 GE Healthcare

7.14.1 GE Healthcare Profile

7.14.2 GE Healthcare Main Business

7.14.3 GE Healthcare Personalized Medicines Products, Services and Solutions

7.14.4 GE Healthcare Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.14.5 GE Healthcare Recent Developments

7.15 Pfizer

7.15.1 Pfizer Profile

7.15.2 Pfizer Main Business

7.15.3 Pfizer Personalized Medicines Products, Services and Solutions

7.15.4 Pfizer Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.15.5 Pfizer Recent Developments

7.16 Sanofi

7.16.1 Sanofi Profile

7.16.2 Sanofi Main Business

7.16.3 Sanofi Personalized Medicines Products, Services and Solutions

7.16.4 Sanofi Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.16.5 Sanofi Recent Developments

7.17 23andMe

7.17.1 23andMe Profile

7.17.2 23andMe Main Business

7.17.3 23andMe Personalized Medicines Products, Services and Solutions

7.17.4 23andMe Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.17.5 23andMe Recent Developments

7.18 Illumina

7.18.1 Illumina Profile

7.18.2 Illumina Main Business

7.18.3 Illumina Personalized Medicines Products, Services and Solutions

7.18.4 Illumina Personalized Medicines Revenue (US$ Million) & (2019-2024)

7.18.5 Illumina Recent Developments

8 Industry Chain Analysis

8.1 Personalized Medicines Industrial Chain

8.2 Personalized Medicines Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Personalized Medicines Sales Model

8.5.2 Sales Channel

8.5.3 Personalized Medicines Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Personalized Medicines Market Trends

Table 2. Personalized Medicines Market Drivers & Opportunity

Table 3. Personalized Medicines Market Challenges

Table 4. Personalized Medicines Market Restraints

Table 5. Global Personalized Medicines Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Personalized Medicines Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Personalized Medicines Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Personalized Medicines Product Type

Table 9. Key Companies Time to Begin Mass Production of Personalized Medicines

Table 10. Global Personalized Medicines Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Personalized Medicines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Personalized Medicines Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Personalized Medicines Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Personalized Medicines Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Personalized Medicines Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Personalized Medicines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Personalized Medicines Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Personalized Medicines Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Personalized Medicines Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Personalized Medicines Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Personalized Medicines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Personalized Medicines Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Personalized Medicines Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Personalized Medicines Sales Value by Region (2019-2024) & (%)

Table 27. Global Personalized Medicines Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Personalized Medicines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Personalized Medicines Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Personalized Medicines Sales Value, (2025-2030) & (US$ Million)

Table 31. 3G Biotech Basic Information List

Table 32. 3G Biotech Description and Business Overview

Table 33. 3G Biotech Personalized Medicines Products, Services and Solutions

Table 34. Revenue (US$ Million) in Personalized Medicines Business of 3G Biotech (2019-2024)

Table 35. 3G Biotech Recent Developments

Table 36. Quest Diagnostics Basic Information List

Table 37. Quest Diagnostics Description and Business Overview

Table 38. Quest Diagnostics Personalized Medicines Products, Services and Solutions

Table 39. Revenue (US$ Million) in Personalized Medicines Business of Quest Diagnostics (2019-2024)

Table 40. Quest Diagnostics Recent Developments

Table 41. Laboratory Corporation of America Basic Information List

Table 42. Laboratory Corporation of America Description and Business Overview

Table 43. Laboratory Corporation of America Personalized Medicines Products, Services and Solutions

Table 44. Revenue (US$ Million) in Personalized Medicines Business of Laboratory Corporation of America (2019-2024)

Table 45. Laboratory Corporation of America Recent Developments

Table 46. Abbott Basic Information List

Table 47. Abbott Description and Business Overview

Table 48. Abbott Personalized Medicines Products, Services and Solutions

Table 49. Revenue (US$ Million) in Personalized Medicines Business of Abbott (2019-2024)

Table 50. Abbott Recent Developments

Table 51. Agendia NV Basic Information List

Table 52. Agendia NV Description and Business Overview

Table 53. Agendia NV Personalized Medicines Products, Services and Solutions

Table 54. Revenue (US$ Million) in Personalized Medicines Business of Agendia NV (2019-2024)

Table 55. Agendia NV Recent Developments

Table 56. Asuragen Inc Basic Information List

Table 57. Asuragen Inc Description and Business Overview

Table 58. Asuragen Inc Personalized Medicines Products, Services and Solutions

Table 59. Revenue (US$ Million) in Personalized Medicines Business of Asuragen Inc (2019-2024)

Table 60. Asuragen Inc Recent Developments

Table 61. Becton Dickinson Basic Information List

Table 62. Becton Dickinson Description and Business Overview

Table 63. Becton Dickinson Personalized Medicines Products, Services and Solutions

Table 64. Revenue (US$ Million) in Personalized Medicines Business of Becton Dickinson (2019-2024)

Table 65. Becton Dickinson Recent Developments

Table 66. CardioDx Inc. Basic Information List

Table 67. CardioDx Inc. Description and Business Overview

Table 68. CardioDx Inc. Personalized Medicines Products, Services and Solutions

Table 69. Revenue (US$ Million) in Personalized Medicines Business of CardioDx Inc. (2019-2024)

Table 70. CardioDx Inc. Recent Developments

Table 71. Foundation Medicine Basic Information List

Table 72. Foundation Medicine Description and Business Overview

Table 73. Foundation Medicine Personalized Medicines Products, Services and Solutions

Table 74. Revenue (US$ Million) in Personalized Medicines Business of Foundation Medicine (2019-2024)

Table 75. Foundation Medicine Recent Developments

Table 76. Qiagen Basic Information List

Table 77. Qiagen Description and Business Overview

Table 78. Qiagen Personalized Medicines Products, Services and Solutions

Table 79. Revenue (US$ Million) in Personalized Medicines Business of Qiagen (2019-2024)

Table 80. Qiagen Recent Developments

Table 81. Siemens Healthcare Basic Information List

Table 82. Siemens Healthcare Description and Business Overview

Table 83. Siemens Healthcare Personalized Medicines Products, Services and Solutions

Table 84. Revenue (US$ Million) in Personalized Medicines Business of Siemens Healthcare (2019-2024)

Table 85. Siemens Healthcare Recent Developments

Table 86. Amgen Basic Information List

Table 87. Amgen Description and Business Overview

Table 88. Amgen Personalized Medicines Products, Services and Solutions

Table 89. Revenue (US$ Million) in Personalized Medicines Business of Amgen (2019-2024)

Table 90. Amgen Recent Developments

Table 91. Bristol-Myers Squibb Basic Information List

Table 92. Bristol-Myers Squibb Description and Business Overview

Table 93. Bristol-Myers Squibb Personalized Medicines Products, Services and Solutions

Table 94. Revenue (US$ Million) in Personalized Medicines Business of Bristol-Myers Squibb (2019-2024)

Table 95. Bristol-Myers Squibb Recent Developments

Table 96. GE Healthcare Basic Information List

Table 97. GE Healthcare Description and Business Overview

Table 98. GE Healthcare Personalized Medicines Products, Services and Solutions

Table 99. Revenue (US$ Million) in Personalized Medicines Business of GE Healthcare (2019-2024)

Table 100. GE Healthcare Recent Developments

Table 101. Pfizer Basic Information List

Table 102. Pfizer Description and Business Overview

Table 103. Pfizer Personalized Medicines Products, Services and Solutions

Table 104. Revenue (US$ Million) in Personalized Medicines Business of Pfizer (2019-2024)

Table 105. Pfizer Recent Developments

Table 106. Sanofi Basic Information List

Table 107. Sanofi Description and Business Overview

Table 108. Sanofi Personalized Medicines Products, Services and Solutions

Table 109. Revenue (US$ Million) in Personalized Medicines Business of Sanofi (2019-2024)

Table 110. Sanofi Recent Developments

Table 111. 23andMe Basic Information List

Table 112. 23andMe Description and Business Overview

Table 113. 23andMe Personalized Medicines Products, Services and Solutions

Table 114. Revenue (US$ Million) in Personalized Medicines Business of 23andMe (2019-2024)

Table 115. 23andMe Recent Developments

Table 116. Illumina Basic Information List

Table 117. Illumina Description and Business Overview

Table 118. Illumina Personalized Medicines Products, Services and Solutions

Table 119. Revenue (US$ Million) in Personalized Medicines Business of Illumina (2019-2024)

Table 120. Illumina Recent Developments

Table 121. Key Raw Materials Lists

Table 122. Raw Materials Key Suppliers Lists

Table 123. Personalized Medicines Downstream Customers

Table 124. Personalized Medicines Distributors List

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

Table 128. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Personalized Medicines Product Picture

Figure 2. Global Personalized Medicines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Personalized Medicines Sales Value (2019-2030) & (US$ Million)

Figure 4. Personalized Medicines Report Years Considered

Figure 5. Global Personalized Medicines Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Personalized Medicines Revenue in 2023

Figure 7. Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. PM Diagnostics Picture

Figure 9. PM Therapeutics Picture

Figure 10. Personalized Medical Care Picture

Figure 11. Personalized Nutrition & Wellness Picture

Figure 12. Global Personalized Medicines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Personalized Medicines Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Hospitals Pharmacies

Figure 15. Product Picture of Retail Pharmacies

Figure 16. Product Picture of Dietary Care Centers

Figure 17. Product Picture of Others

Figure 18. Global Personalized Medicines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Personalized Medicines Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Personalized Medicines Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Personalized Medicines Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Personalized Medicines Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Personalized Medicines Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Personalized Medicines Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Personalized Medicines Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Personalized Medicines Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Personalized Medicines Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Personalized Medicines Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Personalized Medicines Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Personalized Medicines Sales Value (%), (2019-2030)

Figure 31. United States Personalized Medicines Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Personalized Medicines Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Personalized Medicines Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Personalized Medicines Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Personalized Medicines Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Personalized Medicines Sales Value by Application (%), 2023 VS 2030

Figure 37. China Personalized Medicines Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Personalized Medicines Sales Value by Type (%), 2023 VS 2030

Figure 39. China Personalized Medicines Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Personalized Medicines Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Personalized Medicines Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Personalized Medicines Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Personalized Medicines Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Personalized Medicines Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Personalized Medicines Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Personalized Medicines Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Personalized Medicines Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Personalized Medicines Sales Value by Application (%), 2023 VS 2030

Figure 49. India Personalized Medicines Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Personalized Medicines Sales Value by Type (%), 2023 VS 2030

Figure 51. India Personalized Medicines Sales Value by Application (%), 2023 VS 2030

Figure 52. Personalized Medicines Industrial Chain

Figure 53. Personalized Medicines Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Personalized Medicines in 2030? zhanKai

The global market size of Personalized Medicines in 2030 was 540120 Million USD.

Which region is expected to have the highest market share? shouQi

What was the global market size of Personalized Medicines in 2024? shouQi

Which companies rank high in the global Personalized Medicines market? shouQi

What is the annual compound growth rate of the global Personalized Medicines market size from 2024 to 2030? shouQi

Related Reports

Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Personalized Medicines was estimated to be worth US$ 350760 million in 2025 and is projected to reach US$ 714300 million, growing at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 139
USD 3950.00
(Single User License)
Global Personalized Medicines Market Research Report 2026
The global Personalized Medicines market was valued at US$ 350760 million in 2025 and is anticipated to reach US$ 714300 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 129
USD 2900.00
(Single User License)
Global Personalized Medicines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Personalized Medicines market size was US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 101
USD 4250.00
(Single User License)
Global Personalized Medicines Market Research Report 2025
The global market for Personalized Medicines was valued at US$ 319550 million in the year 2024 and is projected to reach a revised size of US$ 650760 million by 2031, growing at a CAGR of 10.9% during the forecast period.
Published Date: 2025-02-27
Pages: 96
USD 2900.00
(Single User License)
Personalized Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Personalized Medicines was estimated to be worth US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 137
USD 3950.00
(Single User License)
Global Personalized Medicines Market Insights, Forecast to 2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published Date: 2024-04-25
Pages: 117
USD 4900.00
(Single User License)
Global Personalized Medicines Market Research Report 2024
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published Date: 2024-01-11
Pages: 91
USD 2900.00
(Single User License)

Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Personalized Medicines was estimated to be worth US$ 350760 million in 2025 and is projected to reach US$ 714300 million, growing at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-07-15
Pages: 139
USD 3950.00 (Single User License)
Global Personalized Medicines Market Research Report 2026
The global Personalized Medicines market was valued at US$ 350760 million in 2025 and is anticipated to reach US$ 714300 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-04-28
Pages: 129
USD 2900.00 (Single User License)
Global Personalized Medicines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Personalized Medicines market size was US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 101
USD 4250.00 (Single User License)
Global Personalized Medicines Market Research Report 2025
The global market for Personalized Medicines was valued at US$ 319550 million in the year 2024 and is projected to reach a revised size of US$ 650760 million by 2031, growing at a CAGR of 10.9% during the forecast period.
Published: 2025-02-27
Pages: 96
USD 2900.00 (Single User License)
Personalized Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Personalized Medicines was estimated to be worth US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 137
USD 3950.00 (Single User License)
Global Personalized Medicines Market Insights, Forecast to 2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published: 2024-04-25
Pages: 117
USD 4900.00 (Single User License)
Global Personalized Medicines Market Research Report 2024
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published: 2024-01-11
Pages: 91
USD 2900.00 (Single User License)